Early research (Phase 1)Study completedNCT04852419What this trial is testingA PHASE 1B STUDY OF ZN-C5 IN CHINESE SUBJECTSWho this might be right forBreast Neoplasms Zentera Therapeutics HK Limited 12
Early research (Phase 1)Ended earlyNCT02384746What this trial is testingPhase I Study of the Combination of MLN9708 and FulvestrantWho this might be right forBreast Cancer Dartmouth-Hitchcock Medical Center 9
Testing effectiveness (Phase 2)WithdrawnNCT01013506What this trial is testingPhase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast CancerWho this might be right forBreast Cancer Vanderbilt-Ingram Cancer Center
Not applicableNot Yet RecruitingNCT07562399What this trial is testingAdjuvant Endocrine Therapy Adherence Intervention Pilot in RwandaWho this might be right forMedication AdherenceBreast Cancer Dana-Farber Cancer Institute 224
Early research (Phase 1)Study completedNCT04546347What this trial is testingAssess the Rel Bioavailability, Food Effect and Absolute Bioavailability on the Pharmacokinetics of AZD9833Who this might be right forHealthy Volunteers AstraZeneca 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT04576455What this trial is testingA Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)Who this might be right forEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer Hoffmann-La Roche 303
Not applicableStudy completedNCT00966043What this trial is testingPrevalence of Genetic Polymorphisms in Genes Coding for Tamoxifen Metabolising EnzymesWho this might be right forBreast Neoplasms Vlaamse Vereniging voor Obstetrie en Gynaecologie 158
Not applicableEnded earlyNCT01346579What this trial is testingBiomarkers in Tissue Samples From Older Women With Breast CancerWho this might be right forBreast Cancer Alliance for Clinical Trials in Oncology 505
Early research (Phase 1)Study completedNCT01339442What this trial is testingBKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast CancerWho this might be right forEstrogen Receptor-positive Breast CancerRecurrent Breast CancerStage IV Breast Cancer Washington University School of Medicine 31
Testing effectiveness (Phase 2)Study completedNCT03213041What this trial is testingPembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast CancerWho this might be right forEstrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+4 more Northwestern University 12
Testing effectiveness (Phase 2)UnknownNCT03192293What this trial is testingMetformin and Simvastatin in Addition to FulvestrantWho this might be right forBreast Cancer National University Hospital, Singapore 28
Not applicableEnded earlyNCT06126003What this trial is testingGut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.Who this might be right forBreast Cancer BioCorteX Inc 2
Not applicableStudy completedNCT02057536What this trial is testingThe Effect of an Exercise Program in Breast Cancer Patients With Joint Pain While Taking Aromatase Inhibitors.Who this might be right forWomen With ER Positive Breast Cancer Taking (AI) w Joint Discomfort and Stiffness Christiana Care Health Services 30
Large-scale testing (Phase 3)Study completedNCT00265759What this trial is testingExemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast CancerWho this might be right forBreast Cancer Alliance for Clinical Trials in Oncology 622
Not applicableStudy completedNCT00975676What this trial is testingStudy of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02Who this might be right forBreast Cancer ETOP IBCSG Partners Foundation 123
Testing effectiveness (Phase 2)Study completedNCT01791985What this trial is testingAZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL)Who this might be right forBreast Cancer Imperial College London 52
Testing effectiveness (Phase 2)WithdrawnNCT01100489What this trial is testingBreast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast CancerWho this might be right forDuctal Breast Carcinoma in SituEstrogen Receptor-negative Breast CancerEstrogen Receptor-positive Breast Cancer+13 more Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT06938711What this trial is testingA Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Context Therapeutics Inc.
Early research (Phase 1)Study completedNCT02316509What this trial is testingGDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast CancerWho this might be right forBreast Cancer Genentech, Inc. 43
Early research (Phase 1)Study completedNCT03725436What this trial is testingALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid TumorsWho this might be right forAdvanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+12 more M.D. Anderson Cancer Center 28